z-logo
open-access-imgOpen Access
Novel reaction to new cystic fibrosis medication Trikafta
Author(s) -
Stashower Julian,
Carr Patrick,
Miller Virginia,
Zlotoff Barrett
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4116
Subject(s) - medicine , cystic fibrosis , ivacaftor , drug reaction , drug , intensive care medicine , pharmacology , cystic fibrosis transmembrane conductance regulator
We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here